← Companies|Elevation Onc
EL

Elevation Onc

ELEV·NASDAQNew York NYFounded 201930 employees
Micro CapbiotechPublicOncology
Platform: Cl18.2
Market Cap
$0.1B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ELEV)
Loading ELEV stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
ELE-7872ELE-7872Phase 2/32Gene TherapyBCL-2BTKiCTCLACC
ELE-7041ELE-7041Preclinical1NanobodyMeninCGRPantDLBCLADHD
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)
2025-12-08
ELE-7872 Ph3 Readout
CTCL
Past
2026-12-04
ELE-7041 Fast Track
DLBCL
Fast Track
2030-03-26
ELE-7872 Ph3 Readout
CTCL
Ph3 Readout